Internal Medicine, Rheumatology · Washington, DC
NPI
1467893230
Since 2013
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
2300 M St NW
Washington, DC, 20037
Phone (202) 741-3333
Groups this clinician bills Medicare through
Medicare paid, 2024
$182K
11,566 services
Medicare patients, 2024
172
Average age 70
Drug cost, 2024
$1.2M
611 prescriptions
Company payments, 2025
$5,977
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ndelela Nadine Mbuyi was code J1010 (injection, methylprednisolone acetate, 1 mg), 810 times for 18 patients. In total Ndelela Nadine Mbuyi billed 11,566 services in 44 codes, and Medicare paid $182K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-06-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 810 | 18 | $0.09 | $76.44 |
| 99214 Office E&M - Established | Office | 229 | 129 | $95.22 | $22K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 222 | 131 | $13.48 | $2,992 |
| 96413 Chemotherapy Administration | Office | 51 | 13 | $115.97 | $5,915 |
| 99215 Office E&M - Established | Office | 50 | 37 | $137.64 | $6,882 |
| 96365 Intravenous Infusion, Hydration | Office | 23 | 12 | $50.15 | $1,153 |
| 96372 Injection Administration | Office | 19 | 15 | $12.76 | $242 |
| 99205 Office E&M - New | Office | 17 | 17 | $171.07 | $2,908 |
| 20610 Joint Injection | Office | 14 | 12 | $62.12 | $870 |
By year: 2022 $221K for 9,802 services; 2023 $205K for 9,876 services; 2024 $182K for 11,566 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ndelela Nadine Mbuyi prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 100 prescriptions and refills. In total Ndelela Nadine Mbuyi wrote 611 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 100 | 236 | 26 | $3,426 |
| Hydroxychloroquine Sulfate Generic | 80 | 208 | 24 | $4,943 |
| Prednisone Generic | 39 | 87 | 19 | $297 |
| Otrexup Methotrexate/Pf | 32 | 32 | Under 11 | $23K |
| Allopurinol Generic | 30 | 90 | 13 | $229 |
| Enbrel Sureclick Etanercept | 23 | 23 | Under 11 | $165K |
| Mycophenolate Mofetil Generic | 23 | 39 | Under 11 | $4,278 |
| Humira(Cf) Pen Adalimumab | 19 | 19 | Under 11 | $136K |
| Colchicine Generic | 19 | 53 | Under 11 | $2,803 |
| Febuxostat Generic | 18 | 26 | Under 11 | $2,773 |
| Leflunomide Generic | 15 | 39 | Under 11 | $703 |
| Actemra Actpen Tocilizumab | 13 | 13 | Under 11 | $68K |
| Cosentyx Syringe Secukinumab | 13 | 13 | Under 11 | $112K |
| Cosentyx Sensoready Pen Secukinumab | 12 | 12 | Under 11 | $89K |
| Xeljanz Tofacitinib Citrate | 11 | 11 | Under 11 | $74K |
Brand drugs: - claims; generic drugs: 401 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ndelela Nadine Mbuyi $5,977 ($2,883 in general payments such as food, travel and fees and $3,094 for research) from 12 companies. The largest payer was Novartis Pharmaceuticals Corporation with $3,094.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 1 | $3,094 |
| Janssen Biotech, Inc. JNJ | 2 | $2,328 |
| Genzyme Corporation SNY | 2 | $198 |
| Amgen Inc. AMGN | 2 | $90 |
| UCB, Inc. UCB.BR | 2 | $62.11 |
| Janssen Scientific Affairs, LLC JNJ | 1 | $43.14 |
| Sobi, Inc SOBI.ST | 1 | $41.91 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $32.14 |
| Aurinia Pharma U.S., Inc. AUPH | 1 | $28.63 |
| Biocon Biologics Inc | 1 | $26.37 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.